The Institute of Molecular Biology is a newly established research centre on the campus of the Johannes Gutenberg University of Mainz, Germany. It is funded by the Boehringer Ingelheim Foundation. The scientists at IMB primarily conduct basic science in developmental biology, epigenetics, and DNA repair.

During the past decade, IKFE - Institute for Clinical Research and Development conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "IKFE - Institute for Clinical Research and Development" #1 collaborator was "IKFE Institute for Clinical Research and Development" with 3 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Novo Nordisk A/S" with 1 trials as a collaborator, "Sanofi" with 1 trials as a collaborator and "Sanofi-Synthelabo" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "IKFE - Institute for Clinical Research and Development" are "Diabetes Mellitus, Type 2" (3 trials), "Diabetes Mellitus" (1 trials) and "Type 2 Diabetes Mellitus With Diabetic Nephropathy" (1 trials). Many other conditions were trialed in "IKFE - Institute for Clinical Research and Development" in a lesser frequency.

Most popular intervention types in "IKFE - Institute for Clinical Research and Development" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "GKT137831" (1 trials), "Metformin and Saxagliptin" (1 trials), "Placebo" (1 trials), "Sugar infusion" (1 trials) and "Victoza®" (1 trials). Other intervention names were less common.

The vast majority of trials in "IKFE - Institute for Clinical Research and Development" are 5 trials for "All" genders.

Currently, there are NaN active trials in "IKFE - Institute for Clinical Research and Development". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in IKFE - Institute for Clinical Research and Development, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in IKFE - Institute for Clinical Research and Development, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".